Living with advanced lung cancer is incredibly difficult. For patients with a specific genetic marker called an EGFR mutation, doctors often use targeted drugs called EGFR-TKIs. New data suggests that adding traditional Chinese medicine to these standard treatments might help these patients keep their cancer from growing for a longer period of time.
Researchers looked at the data and found that patients who received both treatments showed a significant improvement in progression-free survival. This means the combination helped slow down the cancer's growth compared to standard treatment alone. The study specifically looked at patients with advanced non-small cell lung cancer.
While these results are encouraging, it is important to remember that this is an association, not a proven cause. The study did not provide specific details on side effects or how well the treatment was tolerated by patients. You should always talk to your doctor before adding any new treatments to your current cancer care plan.
